Summary

for people ages 1-17 (full criteria)
at Sacramento, California
study started
estimated completion
Stephanie Crossen, MD, MPH

Description

Summary

At the conclusion of this project, investigators will have assessed the effectiveness of home-based telemedicine for improving multiple important clinical and patient-centered outcomes in a high-risk pediatric cohort with T1D. Aim 1. To test the hypothesis that home-based telemedicine is a feasible and acceptable method of care delivery for patients with poorly controlled type 1 diabetes (T1D) currently cared for at the University of California, Davis (UCD) Pediatric Endocrinology clinic. Specifically: A) Patients and families choose to participate in telemedicine visits as a supplement to in-person care; B) Patients and families can utilize secure, internet-based platforms to upload and share glucose meter data and to establish an audio-video connection with a diabetes specialist in their home settings; C) Patients and families are satisfied with the experience of home-based telemedicine and would choose to receive future diabetes care via this modality. Aim 2. To test the hypothesis that using home-based telemedicine, these patients can complete more frequent visits with a diabetes specialist than they previously completed via office visits alone. Aim 3. To test the hypothesis that increased contact with a diabetes specialist via home-based telemedicine will lead to significant improvement in glycemic control for these patients. Aim 4. To evaluate the effects of increased contact with a diabetes specialist via home-based telemedicine on high-cost health care utilization - specifically emergency department (ED) visits and diabetes-related hospitalizations.

Official Title

Use of Home-Based Telemedicine to Improve Healthcare Utilization and Outcomes in Pediatric Patients With Poorly Controlled Type 1 Diabetes

Keywords

Diabetes Mellitus, Type 1 Pediatrics Diabetes Mellitus Telemedicine Intervention

Eligibility

You can join if…

Open to people ages 1-17

  • age 1-17 years
  • known diagnosis of T1D
  • >1 prior visit to the UC Davis Pediatric Endocrinology clinic (to avoid enrolling newly diagnosed patients)
  • suboptimal glycemic control, defined as most recent hemoglobin A1C level of >8%
  • access to the internet via a device with video and audio capability (e.g. computer, tablet, mobile phone)
  • ability to connect their home glucose meter to an internet-capable device via Bluetooth or physical cable for the purpose of data uploading.

You CAN'T join if...

  • Patients and parents whose primary language is not English
  • Patients who have Western Health Advantage health insurance

Location

  • University of California-Davis
    Sacramento California 95817 United States

Lead Scientist

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
Links
Sign up for this study
ID
NCT03374462
Study Type
Interventional
Last Updated